Literature DB >> 22719147

Effect of substrate modification in catheter ablation of paroxysmal atrial fibrillation: pulmonary vein isolation alone or with complex fractionated electrogram ablation.

Gi-Byoung Nam1, Eun-Sun Jin, HyungOh Choi, Hae-Geun Song, Sung-Hwan Kim, Ki-Hun Kim, Eui-Seock Hwang, Kyoung-Min Park, Jun Kim, Kyoung-Suk Rhee, Kee-Joon Choi, You-Ho Kim.   

Abstract

Catheter ablation of atrial fibrillation that targets complex fractionated electrogram sites has been widely applied in the management of persistent atrial fibrillation. The clinical outcomes of pulmonary vein isolation alone and pulmonary vein isolation plus the use of complex fractionated electrogram-guided ablation (CFEA) have not been fully compared in patients with paroxysmal atrial fibrillation.This prospective study included 70 patients with symptomatic paroxysmal atrial fibrillation that remained inducible after pulmonary vein isolation. For radio-frequency catheter ablation, patients were nonrandomly assigned to a control group (pulmonary vein isolation alone, Group 1, n=35) or a CFEA group (pulmonary vein isolation plus additional CFEA, Group 2, n=35). The times to first recurrence of atrial tachyarrhythmias were compared between the 2 groups.In Group 2, CFEA rendered atrial fibrillation noninducible in 16 patients (45.7%) and converted inducible atrial fibrillation into inducible atrial flutters in 12 patients (34.3%). Atrial fibrillation remained inducible in 7 patients (20%) after the combined ablation procedures. After a mean follow-up of 23 months, freedom from recurrence of atrial tachyarrhythmias was significantly higher in Group 2 than in Group 1 (P=0.037). In Group 1, all of the recurrent tachyarrhythmias were atrial fibrillation, whereas regular tachycardia was the major mechanism of recurrent arrhythmias in Group 2 (atrial tachycardia or atrial flutter in 5 of 6 patients and atrial fibrillation in 1 patient).We found that CFEA after pulmonary vein isolation significantly reduced recurrent atrial tachyarrhythmia and might modify the pattern of arrhythmia recurrence in patients with paroxysmal atrial fibrillation.

Entities:  

Keywords:  Atrial fibrillation; atrial flutter; catheter ablation; electrophysiologic techniques, cardiac/methods; heart conduction system/surgery; prospective studies; pulmonary veins/innervation; recurrence; tachycardia

Mesh:

Year:  2012        PMID: 22719147      PMCID: PMC3368479     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  20 in total

1.  Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans.

Authors:  K T Konings; J L Smeets; O C Penn; H J Wellens; M A Allessie
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

2.  Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study.

Authors:  Hakan Oral; Aman Chugh; Kristina Lemola; Peter Cheung; Burr Hall; Eric Good; Jihn Han; Kamala Tamirisa; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

3.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

4.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

5.  Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans.

Authors:  Prashanthan Sanders; Omer Berenfeld; Mélèze Hocini; Pierre Jaïs; Ravi Vaidyanathan; Li-Fern Hsu; Stéphane Garrigue; Yoshihide Takahashi; Martin Rotter; Fréderic Sacher; Christophe Scavée; Robert Ploutz-Snyder; José Jalife; Michel Haïssaguerre
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

6.  Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Hiroshi Tada; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

7.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

Authors:  Koonlawee Nademanee; John McKenzie; Erol Kosar; Mark Schwab; Buncha Sunsaneewitayakul; Thaveekiat Vasavakul; Chotikorn Khunnawat; Tachapong Ngarmukos
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

8.  Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Li-Fern Hsu; Dipen C Shah; Christophe Scavée; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Stéphane Garrigue; Jacques Clémenty; Pierre Jaïs
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

9.  High-density mapping of electrically induced atrial fibrillation in humans.

Authors:  K T Konings; C J Kirchhof; J R Smeets; H J Wellens; O C Penn; M A Allessie
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

Review 10.  Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation.

Authors:  José Jalife; Omer Berenfeld; Moussa Mansour
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  1 in total

1.  Atrial Substrate Modification in Atrial Fibrillation: Targeting GP or CFAE? Evidence from Meta-Analysis of Clinical Trials.

Authors:  Mu Qin; Xu Liu; Shao-Hui Wu; Xiao-Dong Zhang
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.